Organoid Kit Industry Forecasted for Rapid Expansion, Reaching $2.37 Billion by 2029

 Unlock 30% Off Global Market Reports Using Code ONLINE30 — Stay Informed on Trade Policies, Market Growth, and Key Disruptors

 

 What Is the Forecasted Market Size of the Organoid Kit Market by 2029?
 The organoid kit market size has grown rapidly in recent years. It will grow from $1.13 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increasing research in stem cell biology, growing applications in drug toxicity testing, growing use of organoids in cancer research, increasing availability of specialized cell culture media, and growing importance of animal-free testing models.
 
 The organoid kit market size is expected to see rapid growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to an increase in integration with artificial intelligence (AI) and automation, a rise in the use of organoids for gene editing applications, growth in the development of customized organoid kits, a rise in funding for next-generation 3D bioprinting technologies, and growth in the adoption of organoids for rare disease modeling. Major trends in the forecast period include advancement in organ-on-a-chip technology, integration of AI for personalized medicine, innovation in 3D cell culture systems, expansion of organoid-based drug discovery platforms, and collaboration between biotech firms and academic institutions.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28286&type=smp
  
 Which Factors Are Driving Growth in the Organoid Kit Market?
 The increasing incidence of infectious diseases is expected to propel the growth of the organoid kit market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can spread directly or indirectly from one person to another. The rise in infectious diseases is due to poor sanitation and overcrowding, resulting to easier transmission of pathogens and higher infection rates. Organoid kits help to eradicate infectious diseases by enabling researchers to model human tissues in the lab, allowing precise study of pathogen behavior, infection mechanisms, and testing of potential treatments. For instance, in 2025, according to the UK Health Security Agency (UKHSA), a UK-based government agency, tuberculosis (TB) remains a significant public health challenge in England. Additionally, recent data show an 11% increase in reported tuberculosis cases, with nearly 500 additional notifications, rising from 4,380 in 2022 to 4,855 in 2023. Therefore, the increasing incidence of infectious diseases is driving the growth of the organoid kit market.
 
 What Are the Key Segments in the Organoid Kit Market?
 The organoid kit market covered in this report is segmented as
 
 1) By Type, Brain Organoids, Kidney Organoids, Intestinal Organoids, Liver Organoids, Other Organoid Types
 2) By Technology, 3D Cell Culture Technology, Microfluidics Technology, Bioprinting Technology, Electrospinning Technology
 3) By Source, Human-Derived Organoids, Animal-Derived Organoids, Cell Line-Derived Organoids
 4) By Application, Drug Discovery and Development, Disease Modeling, Personalized Medicine, Regenerative Medicine, Other Applications
 5) By End-User, Research Institutes, Pharmaceutical Companies, Contract Research Organizations, Biotech Companies
 
 Subsegments:
 1) By Brain Organoids, Cerebral Organoids, Midbrain Organoids, Retinal Organoids
 2) By Kidney Organoids, Nephron Organoids, Collecting Duct Organoids, Glomerular Organoids
 3) By Intestinal Organoids, Small Intestine Organoids, Colon Organoids, Gastric Organoids
 4) By Liver Organoids, Hepatic Organoids, Cholangiocyte Organoids, Biliary Organoids
 5) By Other Organoid Types, Pancreatic Organoids, Lung Organoids, Heart Organoids, Tumor Organoids
 
 What Are the Emerging Market Trends That Companies Should Monitor in Organoid Kit Market?
 Major companies operating in the organoid kit market are focusing on developing rapid aggregate formations, to accelerate organoid development timelines, improve reproducibility, and enable high-throughput applications for drug discovery, disease modeling, and personalized medicine. Rapid aggregate formation refers to the ability to quickly generate thousands of uniform pluripotent stem cell aggregates in a single day, significantly reducing organoid development time. For instance, in June 2025, Pluristyx Inc., a US-based biotechnology company, launched its PluriForm Organoid Kit, designed to simplify the creation of pluripotent stem cell aggregates and speed up organoid development. The kit offers a ready-to-use platform that shortens the timeline for generating mature organoids from months to just weeks. This integrates optimized growth media and standardized protocols, that ensures reproducible results across various cell types. It also supports high-throughput applications, making it suitable for large-scale disease modeling and drug screening. 
 
 Who Are the Leading Players in the Organoid Kit Market?
 Major companies operating in the organoid kit market are Thermo Fisher Scientific Inc., bioGenous Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Molecular Devices LLC, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., Crown Bioscience International, Creative Biolabs Inc., Emulate Inc., CN Bio Innovations Limited, Novoprotein Scientific Inc., MedChemExpress LLC, Xylyx Bio Inc., MIMETAS B.V., Prellis Biologics Inc., TheWell Bioscience Inc., InSCREENeX GmbH, AMS Biotechnology (Europe) Limited (AMSBIO).
 
 Get the full organoid kit market report here:
 https://www.thebusinessresearchcompany.com/report/organoid-kit-global-market-report
 
 What Are the Key Regional Trends in the Organoid Kit Market?
 North America was the largest region in the organoid kit market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in organoid kit report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company